- Home
- BLDP vs ARVN Comparison
BLDP vs ARVN Comparison
Compare BLDP & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDP
- ARVN
- Stock Information
- Founded
- BLDP 1979
- ARVN 2015
- Country
- BLDP Canada
- ARVN United States
- Employees
- BLDP N/A
- ARVN N/A
- Industry
- BLDP Industrial Machinery/Components
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- BLDP Energy
- ARVN Health Care
- Exchange
- BLDP Nasdaq
- ARVN Nasdaq
- Market Cap
- BLDP 413.8M
- ARVN 456.2M
- IPO Year
- BLDP 1995
- ARVN 2018
- Fundamental
- Price
- BLDP $1.46
- ARVN $7.60
- Analyst Decision
- BLDP Sell
- ARVN Buy
- Analyst Count
- BLDP 11
- ARVN 21
- Target Price
- BLDP $1.71
- ARVN $20.53
- AVG Volume (30 Days)
- BLDP 10.5M
- ARVN 2.2M
- Earning Date
- BLDP 08-11-2025
- ARVN 07-29-2025
- Dividend Yield
- BLDP N/A
- ARVN N/A
- EPS Growth
- BLDP N/A
- ARVN N/A
- EPS
- BLDP N/A
- ARVN N/A
- Revenue
- BLDP $70,668,000.00
- ARVN $426,900,000.00
- Revenue This Year
- BLDP $43.80
- ARVN $4.26
- Revenue Next Year
- BLDP $25.81
- ARVN N/A
- P/E Ratio
- BLDP N/A
- ARVN N/A
- Revenue Growth
- BLDP N/A
- ARVN 498.74
- 52 Week Low
- BLDP $1.00
- ARVN $5.90
- 52 Week High
- BLDP $2.71
- ARVN $34.11
- Technical
- Relative Strength Index (RSI)
- BLDP 50.94
- ARVN 50.63
- Support Level
- BLDP $1.58
- ARVN $7.12
- Resistance Level
- BLDP $1.80
- ARVN $7.85
- Average True Range (ATR)
- BLDP 0.10
- ARVN 0.40
- MACD
- BLDP -0.01
- ARVN 0.04
- Stochastic Oscillator
- BLDP 45.44
- ARVN 45.45
About BLDP Ballard Power Systems Inc.
Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.